Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY
Sanofi
Yoon-Koo Kang; Hyung-Don Kim; Jeong Hwan Yook; Young-Kyu Park; Jong Seok Lee; Young-Woo Kim; Jin Young Kim; Min-Hee Ryu; Sun Young Rha; Ik Joo Chung; In-Ho Kim; Sang Cheul Oh; Young Soo Park; Jae-Ho Cheong; Oh Jeong; Mi Hwa Heo; Hark Kyun Kim; ChoHyun Park; Chang Hak Yoo; Seok Yun Kang; Dae Young Zang; You Jin Jang; Ji Young Sul; Jong Gwang Kim; Beom Su Kim; Seung-Hoon Beom; Jun-Eul Hwang; Seung Wan Ryu; Myeong-Cherl Kook; Baek-Yeol Ryoo; Hyunki Kim; Moon-Won Yoo; Nam Su Lee; Sang Ho Lee; Sung Hoon Noh